ChromaDex (NASDAQ:CDXC) has expanded its industry-leading reference standards business with a new line of cannabinoid (CBD) reference standards available to researchers across the globe. These new materials are for laboratory use only, not for human consumption.
The Company welcomes two cannabinoid reference standards, Cannabidiol and Cannabidivarin (CBD-V), derived from hemp for laboratory use in the identification and qualification of hemp and CBD ingredients or products.